Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA ...
Accumulation of a protein called TDP-43 is a key feature of ALS and frontotemporal dementia. In a study published in Neuron, ...
6d
News-Medical.Net on MSNScientists develop lab model to study TDP-43 accumulation in neurodegenerationAccumulation of a protein called TDP-43 is a key feature of ALS and frontotemporal dementia. In a newly published study, ...
Scientists at Oak Ridge National Laboratory have developed the first-ever method of detecting ribonucleic acid, or RNA, ...
Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced Genedata Chromatics® , a unique vendor-agnostic software platform for managing and analyzing ...
The "RNA Analysis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets.com's offering.The Global RNA Analysis Market was ...
ORNL scientists introduce a biosensor for real-time RNA monitoring in plants, promising advancements in agriculture and ...
Quantoom Biosciences and DIANT Pharma Inc. Collaborate to Enhance mRNA Supply Chain Efficiency Quantoom Biosciences and DIANT Pharma Inc. are proud to announce a strategic collaboration to advance the ...
ORNL scientists created a biosensor technology that lets researchers visualize and track RNA activity in living plants, using ...
Researchers at UCSF discovered that regulatory T cells (T-regs) in the meninges produce natural opioids, and their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results